meprobamate has been researched along with Dominant Hereditary Sensory Neuropathy, Type III in 2 studies
Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goulon, M | 1 |
| Nouailhat, F | 1 |
| Lévy-Alcover, MA | 1 |
| Dordain, G | 1 |
2 other studies available for meprobamate and Dominant Hereditary Sensory Neuropathy, Type III
| Article | Year |
|---|---|
[Toxic coma with autonomic sideration, with a favorable outcome].
Topics: Adult; Amobarbital; Body Temperature; Brain; Cardiovascular System; Chlorpromazine; Coma; Diazepam; | 1967 |
[Pathibamat].
Topics: Biliary Dyskinesia; Dysautonomia, Familial; Gastrointestinal Diseases; Humans; Meprobamate; Parasymp | 1965 |